Cargando…
The COVID-19 pandemic and new clinical trial activations
BACKGROUND: The COVID-19 pandemic has caused severe disruptions in care for many patients. A key question is whether the landscape of clinical research has also changed. METHODS: In a retrospective cohort study, we examined the association of the COVID-19 outbreak with new clinical trial activations...
Autores principales: | Unger, Joseph M., Xiao, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027975/ https://www.ncbi.nlm.nih.gov/pubmed/33832534 http://dx.doi.org/10.1186/s13063-021-05219-3 |
Ejemplares similares
-
Cancer Clinical Trial Participation at the 1-Year Anniversary of the Outbreak of the COVID-19 Pandemic
por: Unger, Joseph M., et al.
Publicado: (2021) -
Association of the COVID-19 Outbreak With Patient Willingness to Enroll in Cancer Clinical Trials
por: Fleury, Mark E., et al.
Publicado: (2020) -
Sex, Racial, and Ethnic Representation in COVID-19 Clinical Trials: A Systematic Review and Meta-analysis
por: Xiao, Hong, et al.
Publicado: (2022) -
Association of the Coronavirus Disease 2019 (COVID-19) Outbreak With Enrollment in Cancer Clinical Trials
por: Unger, Joseph M., et al.
Publicado: (2020) -
Geographic social inequalities in information-seeking response to the COVID-19 pandemic in China: longitudinal analysis of Baidu Index
por: Wang, Zhicheng, et al.
Publicado: (2022)